{"title":"PULMONARY ADVERSE REACTIONS OF CARDIOVASCULAR DRUGS","authors":"Y. Mostovoy, T. Danilevych","doi":"10.31215/2306-4927-2022-30-1-15-24","DOIUrl":null,"url":null,"abstract":"PULMONARY ADVERSE REACTIONS OF CARDIOVASCULAR DRUGS Y. M. Mostovoy, T. D. Danilevych Abstract Diagnosis and treatment of chronic obstructive pulmonary disease, bronchial asthma, pneumonia, idiopathic pulmonary fibrosis is an actual problem in medicine and pulmonology. These diseases are quite often combined with common diseases of the cardiovascular system, in particular, coronary artery disease, hypertension, and heart failure. The supervision of such patients is a difficult problem for the physicians. This review focuses on published data regarding the use of common drugs for the treatment of the cardiovascular diseases, such as angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, antiplatelet agents, statins, antiarrhythmic drugs, etc. Special emphasis has been made on pulmonary adverse reaction of these medications. Key words: amiodarone, angiotensin-converting enzyme inhibitors, beta-blockers, acetylsalicylic acid, statins, pulmonary adverse reactions.","PeriodicalId":328937,"journal":{"name":"Ukrainian Pulmonology Journal","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukrainian Pulmonology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31215/2306-4927-2022-30-1-15-24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
PULMONARY ADVERSE REACTIONS OF CARDIOVASCULAR DRUGS Y. M. Mostovoy, T. D. Danilevych Abstract Diagnosis and treatment of chronic obstructive pulmonary disease, bronchial asthma, pneumonia, idiopathic pulmonary fibrosis is an actual problem in medicine and pulmonology. These diseases are quite often combined with common diseases of the cardiovascular system, in particular, coronary artery disease, hypertension, and heart failure. The supervision of such patients is a difficult problem for the physicians. This review focuses on published data regarding the use of common drugs for the treatment of the cardiovascular diseases, such as angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, antiplatelet agents, statins, antiarrhythmic drugs, etc. Special emphasis has been made on pulmonary adverse reaction of these medications. Key words: amiodarone, angiotensin-converting enzyme inhibitors, beta-blockers, acetylsalicylic acid, statins, pulmonary adverse reactions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
